/Companies

Indee Labs

YC W17

San Francisco, US · Founded 2015 · 5 employees · 7 known investors

Find your way into Indee Labs

Sign up to see every warm intro you have to Indee Labs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Indee Labs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Indee Labs develops Hydropore™, a non-viral microfluidic technology for delivering molecules, nucleic acids, proteins, and gene-editing complexes into immune cells for engineered cell therapy research and manufacturing. The platform enables rapid production of high-quality T-cell immunotherapies and other cell therapies with preserved cell function.

Also known as Indee, Inc.

BiotechDeep TechHealthtechMedical DevicesGene TherapyMicrofluidicsCell TherapyUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W17)

Indee Labs was founded in 2015 by Ryan Pawell.

RPRyan Pawell
Ryan PawellFounder · Chief Executive OfficerRyan Pawell is founder and CEO of Indee Labs, which develops microfluidic technology for delivering molecules and genetic materials into immune cells for cell therapy research and manufacturing. He has presented research at institutions including the National Institutes of Health, National Cancer Institute, Stanford, UC San Francisco, and Mayo Clinic, and has worked with venture investors and government research programs in the biotechnology space.
EW
Eva WellesHR Consultant
AL
Adrian LievanoBioengineerformer
AT
Amy Twite,

Investors · 7

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 4

Companies working in the same space as Indee Labs.

Non-dilutive funding · 5 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$295.9K
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$309.6K
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$399.3K
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$300K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Legal entities · 1

corporate structure
Indee, Inc.

In the news

Frequently asked questions

What does Indee Labs do?
Indee Labs develops Hydropore™, a non-viral microfluidic technology for delivering molecules, nucleic acids, proteins, and gene-editing complexes into immune cells for engineered cell therapy research and manufacturing. The platform enables rapid production of high-quality T-cell immunotherapies and other cell therapies with preserved cell function.
Who founded Indee Labs?
Indee Labs was founded by Ryan Pawell in 2015.
Who are Indee Labs's investors?
Indee Labs's investors include Jude Gomila, Pioneer, SOSV, Y Combinator, BroadOak Capital Partners, Founders Fund, Main Sequence Ventures.
Where is Indee Labs headquartered?
Indee Labs is headquartered in San Francisco, US.